Background The quality SLNB for breast cancer has never been evaluated on a population
level. We previously developed SLNB quality indicators (QIs) and measured them at a single …

Background Measurement of the quality of sentinel lymph node biopsy (SLNB) has not been
reported beyond the false-negative rate and sentinel lymph node identification rate. This …

Background Sentinel lymph node biopsy (SLNB) has become the preferred method for
axillary nodal staging. The authors examined SLNB utilization in urban versus rural settings …

Sentinel lymph node biopsy (SLNB) in breast cancer has not been readily adopted into
Canadian surgical practice in comparison with the United States. We sought to evaluate …

Background Sentinel lymph node biopsy (SNLB) has been adopted as the standard method
of axillary staging for women with clinically node-negative early-stage breast cancer. The …

Background and Objectives The purpose of this study was to assess the number of lymph
nodes removed at SLNB, and what factors might bias a surgeon's decision to remove …

Background Sentinel lymph node biopsy (SLNB), an acceptable alternative to axillary lymph
node dissection for staging patients with breast cancer, was introduced to clinical practice in …

Background: Recent data suggest sentinel lymph node biopsy (SLNBx) for invasive breast
cancer (IBC) is widely performed in the United States, often outside of a clinical trial. We …

Abstract Quality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer: Applicability
and Clinical Relevance in a Non-screened Population: sentinel lymph node biopsy (SLNB) …

BACKGROUND: We sought to determine whether the results of sentinel lymph node (SLN)
biopsy are related to practice and community factors. METHODS: This prospective study …